The deal, a concentrated-asset GP-led secondaries process, is among a few that have been able to navigate to final close this year despite the widening bid/ask spread.
3 min read · 24 October 2022
Hans Swildens, Jonathan Ting and Wade Cobb of Industry Ventures give six predictions on the rapidly growing VC secondaries market.
6 min read · 24 October 2022
Harvest’s tender offer sale is among several that GPs are using to give existing LPs an option to generate liquidity, while trying to boost new fundraisings.
3 min read · 20 October 2022
There is misalignment between investors and GPs on the topics of obstacles, red flags and expectations, a Capstone survey finds – however, the market is expected to go through further standardisation.
3 min read · 19 October 2022
We catch up with William Greene, managing partner at Stafford Capital Partners, to discuss why some LPs are parting ways with stakes in infra funds and how big this market could become.
1 min read · 19 October 2022
Investors who do not participate in GP-led secondaries could be incurring an opportunity cost of at least 15% over the long run, a study by Upwelling Capital Group has found.
4 min read · 18 October 2022
Nordic mid-market buyout house Adelis Equity Partners has rolled in-vitro diagnostics company SSI Diagnostica into a single-asset continuation fund.
2 min read · 18 October 2022
Cathay Life Insurance tops the list of the largest known investors in secondaries, committing $2.42bn to funds with a vintage year of between 2016 and 2022.
2 min read · 17 October 2022
The system won’t sell any assets to meet its target despite the denominator effect’s impact.
2 min read · 17 October 2022
The firm has followed the recruitment of an Asia real estate head on the direct side with a second appointment intended to lead its indirect investments in the region.
2 min read · 14 October 2022
